- Filed
- Apr 11, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Mar 31, 2025 | 58.43M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2024 | 42.82M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2024 | 42.85M sh |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 44.28M sh |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 44.63M sh |
| Stock Repurchased | Q2 2024 · Jun 30, 2024 | $1.93M |
| Stock Repurchased | Q2 2024 · Jun 30, 2023 | $3.07M |
| Dividends Paid | Q2 2024 · Jun 30, 2024 | $985K |
| Dividends Paid | Q2 2024 · Jun 30, 2023 | $557K |
| Capex | Q2 2024 · Jun 30, 2024 | $2.39M |
| Capex | Q2 2024 · Jun 30, 2023 | $2.45M |
| Operating Cash Flow | Q2 2024 · Jun 30, 2024 | $3.81M |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$16.67M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $8.08M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $20.78M |
| Stockholders Equity | Q2 2024 · Jun 30, 2024 | $158.8M |
| Stockholders Equity | Q2 2024 · Mar 31, 2024 | $165.62M |
| Stockholders Equity | Q2 2024 · Dec 31, 2023 | $176.64M |
| Stockholders Equity restated | Q2 2024 · Jun 30, 2023 | $177.97M |
| Stockholders Equity restated | Q2 2024 · Mar 31, 2023 | $192.36M |
| Stockholders Equity restated | Q2 2024 · Dec 31, 2022 | $198.51M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $33.6M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $28.99M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $50.72M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $46.46M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $115.65M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $127.66M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $209.52M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $236.3M |
| Eps Diluted | Q2 2024 · Jun 30, 2024 | −$0.20 |
| Eps Diluted | Q2 2024 · Jun 30, 2024 | −$0.43 |
| Eps Diluted restated | Q2 2024 · Jun 30, 2023 | −$0.28 |
| Eps Diluted restated | Q2 2024 · Jun 30, 2023 | −$0.39 |
| Eps Basic | Q2 2024 · Jun 30, 2024 | −$0.20 |
| Eps Basic | Q2 2024 · Jun 30, 2024 | −$0.43 |
| Eps Basic restated | Q2 2024 · Jun 30, 2023 | −$0.28 |
| Eps Basic restated | Q2 2024 · Jun 30, 2023 | −$0.39 |
| Net Income | Q2 2024 · Jun 30, 2024 | −$7.85M |
| Net Income | Q2 2024 · Jun 30, 2024 | −$17.42M |
| Net Income restated | Q2 2024 · Jun 30, 2023 | −$11.99M |
| Net Income restated | Q2 2024 · Jun 30, 2023 | −$16.9M |
| Operating Income | Q2 2024 · Jun 30, 2024 | −$9.52M |
| Operating Income | Q2 2024 · Jun 30, 2024 | −$20.45M |
| Operating Income restated | Q2 2024 · Jun 30, 2023 | −$14.51M |
| Operating Income restated | Q2 2024 · Jun 30, 2023 | −$23.51M |